Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Buy
+9,380
New +$245K 0.01% 231
2017
Q1
Sell
-564,976
Closed -$17.4M 195
2016
Q4
$17.4M Sell
564,976
-504,181
-47% -$15.4M 1.49% 22
2016
Q3
$34.4M Sell
1,069,157
-10,540
-1% -$352K 1.22% 12
2016
Q2
$36.1M Buy
1,079,697
+35,204
+3% +$1.12M 1.86% 10
2016
Q1
$29.4M Buy
1,044,493
+17,918
+2% +$512K 2.3% 13
2015
Q4
$31.4M Buy
1,026,575
+8,221
+0.8% +$259K 1.19% 9
2015
Q3
$30.3M Buy
1,018,354
+125,321
+14% +$4.02M 1.86% 7
2015
Q2
$28.4M Buy
893,033
+5,059
+0.6% +$165K 2.15% 9
2015
Q1
$29.3M Buy
887,974
+487,243
+122% +$15.5M 2.33% 7
2014
Q4
$11.8M Buy
400,731
+2,319
+0.6% +$66.5K 0.88% 27
2014
Q3
$11.2M Sell
398,412
-426,870
-52% -$12M 0.59% 25
2014
Q2
$23.2M Buy
825,282
+222,499
+37% +$6.34M 1.44% 17
2014
Q1
$18.4M Buy
602,783
+114,886
+24% +$3.43M 1.59% 15
2013
Q4
$14.2M Buy
+487,897
New +$14.2M 1.03% 20

Other funds holding PFE

Sprott Inc's PFE Position: Q2 2026 in Review

Sprott Inc opened a new position in Pfizer (PFE) in Q2 2026: 9,380 shares worth $226K. The stake represents 0.01% of the portfolio and ranks #231 among its holdings. This is a return to the name: Sprott Inc previously reported a position in PFE as recently as Q4 2016.

Sprott Inc first reported a position in PFE in Q4 2013 and has held it in 14 quarters since. The position peaked at $36.1M in Q2 2016. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sprott Inc held 9,380 shares of Pfizer worth $226K as of Q2 2026.
  • Pfizer was a new Sprott Inc position in Q2 2026.
  • Pfizer made up 0.01% of Sprott Inc's portfolio in Q2 2026, its #231 holding.
  • Sprott Inc first reported a position in Pfizer in Q4 2013 and has held it in 14 quarters since.
  • Sprott Inc's Pfizer position peaked at $36.1M in Q2 2016.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sprott Inc's 13F filing for Q2 2026, filed 28 Jul 2026.